BlackRock Global Funds - Global Equity Income Fund I2 EURRegister to Unlock Ratings |
Performance History | 30/04/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | - | - | - | 9.9 | 4.2 | |
+/-Cat | - | - | - | 2.6 | -0.2 | |
+/-B’mrk | - | - | - | 5.1 | -1.3 | |
Category: Global Equity Income | ||||||
Category Benchmark: Morningstar Gbl High Div Yl... |
Key Stats | ||
NAV 15/05/2024 | EUR 16.79 | |
Day Change | 0.36% | |
Morningstar Category™ | Global Equity Income | |
ISIN | LU2533723461 | |
Fund Size (Mil) 30/04/2024 | USD 905.80 | |
Share Class Size (Mil) 15/05/2024 | EUR 206.56 | |
Max Initial Charge | - | |
Ongoing Charge 15/04/2024 | 0.81% |
Investment Objective: BlackRock Global Funds - Global Equity Income Fund I2 EUR |
The Fund seeks an above average income from its equity investments without sacrificing long term capital growth. The Fund invests globally at least 70% of its total assets in the equity securities of companies domiciled in, or exercising the predominant part of their economic activity in, developed markets. Currency exposure is flexibly managed. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Olivia Treharne 01/02/2020 | ||
Molly Greenen 12/01/2022 | ||
Inception Date 12/10/2022 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI ACWI NR USD | Morningstar Gbl High Div Yld NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for BlackRock Global Funds - Global Equity Income Fund I2 EUR | 30/04/2024 |
|
|
Top 5 Holdings | Sector | % |
Microsoft Corp | Technology | 4.70 |
AstraZeneca PLC | Healthcare | 3.39 |
Novo Nordisk A/S Class B | Healthcare | 3.27 |
Taiwan Semiconductor Manufacturi... | Technology | 3.14 |
Texas Instruments Inc | Technology | 3.06 |
Increase Decrease New since last portfolio | ||
BlackRock Global Funds - Global Equity Income Fund I2 EUR |